SCHEMBL6667133

SCHEMBL6667133

CCOC(=O)c1ccc(C#Cc2cccc(N)n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.52
TDP1 Q9NUW8 2/20 0.52
ALDH1A1 P00352 2/20 0.52
NPC1 O15118 1/20 0.52
PKM P14618 1/20 0.52
RAB9A P51151 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
CYP1A2 P05177 2/20 0.50
LMNA P02545 1/20 0.50
CYP3A4 P08684 1/20 0.50
MAOA P21397 1/20 0.50
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
ESR1 P03372 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
ESR2 Q92731 1/20 0.44
CA14 Q9ULX7 1/20 0.44
FFAR1 O14842 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6365625 0.80 CA1 (0.66) MAPTTDP1ALDH1A1NPC1RAB9A
SCHEMBL7494237 0.79 RARB (0.45) ALDH1A1NPC1PKMRAB9ACYP1A2
Hydrochloric Acid SCHEMBL7415587 0.78 NPC1 (0.44) ALDH1A1NPC1PKMRAB9ACYP1A2
SCHEMBL3639721 0.77 MEN1 (0.59) MAPTTDP1ALDH1A1NPC1RAB9A
SCHEMBL16607394 0.76 ACACB (0.39) TDP1CYP1A2LMNACYP3A4MAOA
SCHEMBL14724569 0.76 LMNA (0.59) MAPTTDP1ALDH1A1NPC1RAB9A
SCHEMBL1348968 0.75 CA12 (0.54) MAPTTDP1ALDH1A1NPC1RAB9A
SCHEMBL4710798 0.74 GRM5 (0.54) ALDH1A1NPC1PKMRAB9ACYP1A2
SCHEMBL18400673 0.74 LMNA (0.61) MAPTTDP1ALDH1A1NPC1RAB9A
SCHEMBL10411225 0.74 CA1 (0.61) MAPTTDP1ALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1252162-B1 ALPHA V INTEGRIN RECEPTOR ANTAGONISTS MERCK SHARP & DOHME (US) 2012-07-25 EP disclosed
EP-1315501-B1 ALPHA V INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2007-02-07 EP disclosed
EP-1387688-A2 BENZAZEPINONE ALPHA V INTEGRIN RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2004-02-11 EP disclosed
WO-2002090325-A2 BENZAZEPINONE ALPHA V INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2002-11-14 WO disclosed
EP-0760658-B1 COMPOUNDS FOR INHIBITING OSTEOCLAST-MEDIATED BONE RESORPTION MERCK & CO INC (US) 2002-11-13 EP disclosed
US-5929120-A Guainidino, formamidino, amino and related compounds for inhibiting osteoclast-mediated bone resorption MERCK & CO., INC. (US) 1999-07-27 US disclosed
US-5741796-A Pyridyl and naphthyridyl compounds for inhibiting osteoclast-mediated bone resorption MERCK & CO., INC. (US) 1998-04-21 US disclosed
EP-0760658-A4 COMPOUNDS FOR INHIBITING OSTEOCLAST-MEDIATED BONE RESORPTION MERCK & CO INC (US) 1997-09-17 EP disclosed
EP-0760658-A1 COMPOUNDS FOR INHIBITING OSTEOCLAST-MEDIATED BONE RESORPTION MERCK & CO. INC. (US) 1997-03-12 EP disclosed
WO-1995032710-A1 COMPOUNDS FOR INHIBITING OSTEOCLAST-MEDIATED BONE RESORPTION MERCK & CO., INC. (US) 1995-12-07 WO disclosed